Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders

Movement Disorders, 04/26/2012

Increased monoaminergic activity in the medial orbitofrontal cortex might be associated with increased sensitivity for Impulse control disorders (ICDs) under dopamine–replacement therapy in Parkinson's Disease (PD).

Print Article Summary Cat 2 CME Report